CORC  > 中国医学科学院 北京协和医学院
A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer
Guo Xiao-Fang; Zhu Xiao-Fei; Cao Hai-Ying; Zhong Gen-Shen; Li Liang; Deng Bao-Guo; Chen Ping; Wang Pei-Zhen; Miao Qing-Fang; Zhen Yong-Su
2017
卷号8期号:16页码:27286-27299
关键词EGFR IGF-1R lidamycin bispecific fusion protein NSCLC
ISSN号1949-2553
DOI10.18632/oncotarget.15933
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6367246
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Guo Xiao-Fang,Zhu Xiao-Fei,Cao Hai-Ying,et al. A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer[J],2017,8(16):27286-27299.
APA Guo Xiao-Fang.,Zhu Xiao-Fei.,Cao Hai-Ying.,Zhong Gen-Shen.,Li Liang.,...&Zhen Yong-Su.(2017).A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer.,8(16),27286-27299.
MLA Guo Xiao-Fang,et al."A bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancer".8.16(2017):27286-27299.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace